Paxil is an antidepressant drug manufactured by GlaxoSmithKline. Paxil is prescribed to patients suffering from depression, Obsessive Compulsive Disorder (OCD), anxiety disorders, premenstrual dysphoric disorder (PMDD), and post traumatic stress disorder (PTSD). Paxil is known generically as paroxetine, and is classified as a selective serotonin re-uptake inhibitor (SSRI). The use of SSRI antidepressants, such as Paxil, during pregnancy have a strong link to the development of congenital birth defects in children.
Birth defects linked to exposure to Paxil in the womb include, but are not limited to, the following:
These birth defects cause an unwarranted amount of suffering for a newborn. Congenital heart defects are the most common Paxil birth defects reported. Atrial septal defects and ventricular septal defects are also known as holes in the heart, as during development in the womb, the heart organ does not form properly, thus leaving a hole in a chamber wall. Children exposed to Paxil in the womb quite often show withdrawal symptoms upon birth, when they are no longer constantly exposed to the SSRI antidepressant. Withdrawal symptoms include trouble feeding, shakiness, perpetual irritability, and other uncomfortable and painful health conditions.
For breastfeeding mothers, it is known that Paxil can pass through the breast milk to the feeding child. Exposure to Paxil in this manner, via breast milk, can also cause further damage to the health of a newborn child. Therefore, it is important for nursing mothers to work with their doctors in determining the use of an SSRI antidepressant such as Paxil while breastfeeding.
If your newborn baby has endured pain and suffering due to exposure to Paxil in the womb, you and your baby may be eligible to receive recompense for such unwarranted distress. To file a Paxil lawsuit, contact an experienced Paxil lawyer at Carey Danis & Lowe today. Our pharmaceutical product liability attorneys work hard to insure that our clients win the justice they deserve in lawsuits against negligent pharmaceutical giants like GlaxoSmithKline.
The FDA has categorized Paxil as a Pregnancy D drug meaning that there is positive evidence of an increased risk for congenital birth defects when taken during pregnancy.
Common Paxil birth defects include but are not limited to:
FDA Approval: December 29, 1992 for major depression, OCD & general anxiety in adults
Generic Availability: July 30, 2003
Pregnancy Risk: Category D